News & Publications - Page 2 of 2

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

12

Jan

18
KP415 – APSARD 2018
- Posters

28

Oct

17
KP201/IR – Pain Medicine
- Publications

25

Aug

17
Apadaz® – Pain Medicine
- Publications

03

Aug

17
Apadaz® – Drug Safety
- Publications

19

Mar

17
KP201/IR – AAPM 2017
- Posters

15

Mar

17
KP511 – AAPM 2017
- Posters

11

Jun

16
KP511 – ICOO 2016
- Posters

07

Jun

16
KP201/IR – ICOO 2016
- Posters

05

Jun

16
KP201/IR – ICOO 2016
- Posters